DAVID BATES David.Bates@nottingham.ac.uk
Professor of Oncology
Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity
Bates, David; Ngo, Doan T. M.; Farb, Melissa G.; Kikuchi, Ryosuke; Karki, Shakun; Tiwari, Stephanie; Bigornia, Sherman J.; LaValley, Michael P.; Hamburg, Naomi M.; Vita, Joseph A.; Hess, Donald T.; Walsh, Kenneth; Gokce, Noyan
Authors
Doan T. M. Ngo
Melissa G. Farb
Ryosuke Kikuchi
Shakun Karki
Stephanie Tiwari
Sherman J. Bigornia
Michael P. LaValley
Naomi M. Hamburg
Joseph A. Vita
Donald T. Hess
Kenneth Walsh
Noyan Gokce
Abstract
Background—Experimental studies suggest that visceral adiposity and adipose tissue dysfunction play a central role in obesity-related cardiometabolic complications. Impaired angiogenesis in fat has been implicated in the development of adipose tissue hypoxia, capillary rarefaction, inflammation, and metabolic dysregulation, but pathophysiological mechanisms remain unknown. In this study, we examined the role of a novel antiangiogenic isoform of vascular endothelial growth factor-A (VEGF-A), VEGF-A165b, in human obesity.
Methods and Results—We biopsied paired subcutaneous and visceral adipose tissue in 40 obese subjects (body mass index, 45±8 kg/m2 ; age, 45±11 years) during bariatric surgery and characterized depot-specific adipose tissue angiogenic capacity using an established ex vivo assay. Visceral adipose tissue exhibited significantly blunted angiogenic growth compared with subcutaneous fat (P less than 0.001) that was associated with marked tissue upregulation of VEGF-A165b (P=0.004). The extent of VEGF-A165b expression correlated negatively with angiogenic growth (r=−0.6, P=0.006). Although recombinant VEGF-A165b significantly impaired angiogenesis, targeted inhibition of VEGF-A165b with neutralizing antibody stimulated fat pad neovascularization and restored VEGF receptor activation. Blood levels of VEGF-A165b were significantly higher in obese subjects compared with lean control subjects (P=0.02), and surgical weight loss induced a marked decline in serum VEGF-A165b (P=0.003).
Conclusions—We demonstrate that impaired adipose tissue angiogenesis is associated with overexpression of a novel antiangiogenic factor, VEGF-A165b, that may play a pathogenic role in human adiposopathy. Moreover, systemic upregulation of VEGF-A165b in circulating blood may have wider-ranging implications beyond the adipose milieu. VEGF-A165b may represent a novel area of investigation to gain further understanding of mechanisms that modulate the cardiometabolic consequences of obesity .
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 3, 2014 |
Publication Date | Aug 15, 2014 |
Deposit Date | Jul 10, 2018 |
Print ISSN | 0009-7322 |
Electronic ISSN | 1524-4539 |
Publisher | American Heart Association |
Peer Reviewed | Peer Reviewed |
Volume | 130 |
Issue | 13 |
Pages | 1072-1080 |
DOI | https://doi.org/10.1161/CIRCULATIONAHA.113.008171 |
Public URL | https://nottingham-repository.worktribe.com/output/1114839 |
Publisher URL | https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.113.008171 |
PMID | 25116954 |
You might also like
Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia
(2014)
Journal Article
Direct detection and measurement of wall shear stress using a filamentous bio-nanoparticle
(2015)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search